PEDRON, Serena
 Distribuzione geografica
Continente #
EU - Europa 3.492
NA - Nord America 3.325
AS - Asia 2.241
SA - Sud America 268
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.422
Nazione #
US - Stati Uniti d'America 3.236
RU - Federazione Russa 1.354
SG - Singapore 846
GB - Regno Unito 694
CN - Cina 674
IT - Italia 409
HK - Hong Kong 229
VN - Vietnam 215
SE - Svezia 209
BR - Brasile 203
DE - Germania 198
FR - Francia 143
IE - Irlanda 140
FI - Finlandia 130
KR - Corea 69
CA - Canada 49
ES - Italia 47
IN - India 35
UA - Ucraina 35
NL - Olanda 34
AR - Argentina 32
JP - Giappone 30
BE - Belgio 29
MX - Messico 27
TR - Turchia 27
NG - Nigeria 21
ID - Indonesia 17
PL - Polonia 16
IQ - Iraq 15
BD - Bangladesh 14
ZA - Sudafrica 13
BJ - Benin 12
EC - Ecuador 11
AT - Austria 10
EG - Egitto 10
PH - Filippine 8
TG - Togo 7
KG - Kirghizistan 6
LT - Lituania 6
SA - Arabia Saudita 6
VE - Venezuela 6
CH - Svizzera 5
CO - Colombia 5
CZ - Repubblica Ceca 5
HR - Croazia 5
IL - Israele 5
PK - Pakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AU - Australia 4
IR - Iran 4
KE - Kenya 4
MY - Malesia 4
PY - Paraguay 4
RS - Serbia 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
PT - Portogallo 3
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
CM - Camerun 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
KZ - Kazakistan 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
BB - Barbados 1
CR - Costa Rica 1
GA - Gabon 1
IM - Isola di Man 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MG - Madagascar 1
MK - Macedonia 1
NI - Nicaragua 1
RO - Romania 1
SC - Seychelles 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.422
Città #
Southend 579
Moscow 511
Singapore 456
Ashburn 406
Dallas 368
Chandler 328
San Jose 303
Hong Kong 223
Verona 171
Jacksonville 158
Ann Arbor 151
Dublin 138
Beijing 135
Woodbridge 133
Houston 91
New York 91
The Dalles 87
Los Angeles 72
Munich 66
Ho Chi Minh City 58
Hanoi 54
Helsinki 48
Wilmington 47
Jinan 45
Lawrence 44
Princeton 44
Nanjing 41
Shenyang 38
Madrid 37
Redmond 34
Council Bluffs 32
Tianjin 32
Orem 31
Brussels 29
Turku 28
Buffalo 26
London 26
Santa Clara 26
Tokyo 26
Columbus 23
Redondo Beach 22
Milan 21
Montreal 21
Sindelfingen 21
São Paulo 21
Abuja 20
Guangzhou 19
Seoul 19
Zhengzhou 19
Dearborn 17
Hebei 17
Ningbo 17
Amsterdam 15
Changsha 15
Haikou 15
Hangzhou 15
Chennai 14
Lancaster 14
Mexico City 14
San Francisco 14
Atlanta 13
Nanchang 13
Phoenix 13
Taizhou 13
Toronto 13
Cotonou 12
Düsseldorf 12
Seattle 12
Warsaw 12
Poplar 11
Stockholm 11
Boardman 10
Frankfurt am Main 10
Jakarta 10
Johannesburg 10
Redwood City 10
Rome 10
Denver 9
Dong Ket 9
Florence 9
Jiaxing 9
Bologna 8
Brescia 8
Fairfield 8
Nuremberg 8
Biên Hòa 7
Brooklyn 7
Chicago 7
Da Nang 7
Kyiv 7
Lomé 7
Querétaro 7
Rio de Janeiro 7
Washington 7
Cairo 6
Chions 6
Haiphong 6
Hải Dương 6
Taiyuan 6
Vienna 6
Totale 5.948
Nome #
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 313
Genomic characterization of hepatoid tumors: context matters 260
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 247
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 241
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 239
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 237
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 219
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 208
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 207
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 200
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 194
Linfoma splenico a "cellule della zona marginale": studio dell'espressione di TCL1 e t-bet 192
CATHEPSIN-K IS A SENSITIVE IMMUNOHISTOCHEMICAL MARKER FOR DETECTION OF MICRO-GRANULOMAS IN HYPERSENSITIVITY PNEUMONITIS 192
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 192
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 188
S100P expression in cholangiocarcinoma 186
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 186
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 184
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 182
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 181
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 179
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 177
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 175
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 174
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 173
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 168
ANALISI DEL DNA MEDIANTE FLUORESCENT IN SITU HYBRIDIZATION (FISH) PER L’IDENTIFICAZIONE DI ERRORI DI SCAMBIO DI TESSUTI DOPO PROCEDURE CHIRURGICHE: APPLICAZIONI NELLA PRATICA CLINICA ED IMPLICAZIONI MEDICO LEGALI 168
t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma 167
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 166
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 161
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis 160
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 158
Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors 155
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 150
The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery 147
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Parvalbumin immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 139
TCL1 and CD11c expression in hairy-cell leukemia and their diagnostic role on bone marrow biopsies in the differential diagnosis with splenic marginal zone lymphoma 131
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 130
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 130
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 129
Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma 125
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 124
Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk 118
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1 116
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 112
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms 112
High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs 102
VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations 101
STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma 100
Neurotoxic effects of rotenone and deltamethrin prolonged exposure on adult zebrafish 98
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications 98
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 94
Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion 89
Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism 86
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney 85
SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation 82
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations 79
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 55
Stimulator of interferon genes immunohistochemical expression in the spectrum of extrarenal perivascular epithelioid cell lesions 19
Prognostic stratification of chordoid meningiomas: the role of chromosome 1p/22q Loss 17
Totale 9.559
Categoria #
all - tutte 29.084
article - articoli 24.865
book - libri 0
conference - conferenze 4.219
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 31 50 21
2021/2022501 49 125 26 58 30 18 12 33 16 16 30 88
2022/2023931 58 115 85 161 77 224 7 50 103 8 28 15
2023/2024513 24 37 40 59 76 102 16 23 4 34 83 15
2024/20251.349 58 72 85 193 52 47 60 43 227 88 167 257
2025/20264.393 266 269 389 800 1.155 302 373 212 363 264 0 0
Totale 9.559